A NEW SURGICAL OUTCOME SCORE (SOS) INCLUDING HE4, CA125 AND ASCITES VOLUME CAN PREDICT SURGICAL OUTCOME IN PRIMARY OVARIAN CANCER PATIENTS.

被引：0
|
作者：
Braicu, E. [1 ]
van Gorp, T. [2 ]
Richter, R. [1 ]
Nassir, M. [3 ]
Zeillinger, R. [4 ]
Conicn, N. [5 ]
Tong, D. Cacsire Castillo [4 ]
Mahner, S. [6 ]
Vergote, I. [7 ]
Sehouli, J. [1 ]
机构：
[1] Charite, Dept Gynaecol, D-13353 Berlin, Germany
[2] Univ Hosp Maastricht, Dept Obstet & Gynaecol, Maastricht, Netherlands
[3] Charite Campus Virchow, Dept Gynaecol, Berlin, Germany
[4] Med Univ Vienna, Mol Oncol Grp, Vienna, Austria
[5] Med Univ Innsbruck, Dept Obstet & Gynecol, A-6020 Innsbruck, Austria
[6] Med Univ Hamburg, Clin Gynecol, Hamburg, Germany
[7] Univ Hosp KU Leuven, Dept Obstet & Gynaecol, Louvain, Belgium
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2013年 / 23卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [11] THE DIAGNOSTIC AND PROGNOSTIC VALUE OF HE4 AND CA125 IN OVARIAN CANCER PATIENTS
    Korse, Catharina M.
    Bonfrer, J. M. G.
    van Beurden, M.
    TUMOR BIOLOGY, 2010, 31 : S111 - S111
  • [12] Diagnostic and Prognostic Significance of CA125 and HE4 in Ovarian Cancer Patients
    Bandiera, E.
    Romani, C.
    Specchia, C.
    Zanotti, L.
    Belloli, S.
    Bignotti, E.
    Tassi, R. A.
    Tognon, G.
    Pecorelli, S.
    Ravaggi, A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S539 - S539
  • [13] The role of HE4 in predicting surgical outcome in recurrent ovarian cancer (ROC).
    Braicu, E. I.
    Fotopoulou, C.
    Richter, R.
    Chekerov, R.
    Pietzner, K.
    Hall, C.
    Lichtenegger, W.
    Sehouli, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [14] Prognostic value of HE4 in advanced-stage, high-grade serous ovarian cancer: Analysis of HE4 kinetics during NACT, predicting surgical outcome and recurrence in comparison to CA125
    AlSomairi, Amal
    Himayda, Samah
    Altelmesani, Ahmed
    Lee, Yong Jae
    Lee, Jung-Yun
    GYNECOLOGIC ONCOLOGY, 2024, 181 : 155 - 161
  • [15] HE4 antigen-autoantibody complexes complement CA125 for detecting early stage ovarian cancer and can be elevated with CA125 in preclinical ovarian cancer
    Yang, Wei-Lei
    Lu, Zhen
    Lu, Karen H.
    Menon, Usha
    Kobayashi, Makoto
    Hanash, Samir
    Skates, Steven
    Bast, Robert C.
    CANCER RESEARCH, 2018, 78 (13)
  • [16] The diagnostic performance of the Mindray system in detecting CA125 and HE4 for patients with ovarian cancer
    Feng, Pingfeng
    Chen, Tao
    Wischhusen, Joerg
    Ladbury, Colton
    Vargas-Hernandez, Victor Manuel
    Xiong, Yufeng
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (08)
  • [17] Stability of HE4 and CA125 in blood samples from patients diagnosed with ovarian cancer
    Sandhu, Noreen
    Karlsen, Mona A.
    Hogdall, Claus
    Laursen, Inga A.
    Christensen, Ib J.
    Hogdall, Estrid V. S.
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2014, 74 (06): : 477 - 484
  • [18] The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer
    Zheng, Li-e
    Qu, Jun-ying
    He, Fei
    OPEN MEDICINE, 2016, 11 (01): : 125 - 132
  • [19] Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients Results from the OVCAD study
    Braicu, E. I.
    Fotopoulou, C.
    Van Gorp, T.
    Richter, R.
    Chekerov, R.
    Hall, C.
    Butz, H.
    Castillo-Tong, D. Cacsire
    Mahner, S.
    Zeillinger, R.
    Concin, N.
    Vergote, I.
    Sehouli, J.
    GYNECOLOGIC ONCOLOGY, 2013, 128 (02) : 245 - 251
  • [20] Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?
    Cymbaluk-Ploska, Aneta
    Gargulinska, Paula
    Bulsa, Michal
    Kwiatkowski, Sebastian
    Chudecka-Glaz, Anita
    Michalczyk, Kaja
    DIAGNOSTICS, 2021, 11 (04)
12345